PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 338.00
-4.00 (-1.17%)
Aug 27, 2026, 3:30 PM JST
PhoenixBio Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,423 | 1,565 | 1,541 | 1,715 | 2,124 | 1,324 |
Revenue Growth | -4.63% | 1.56% | -10.15% | -19.26% | 60.42% | 30.70% |
Gross Profit Gross Profit Growth | 1,067 | 1,200 | 1,117 | 1,194 | 1,557 | 727 |
Operating Income Operating Income Growth | -35 | 83 | -136 | 5 | 509 | -168 |
Net Income Net Income Growth | 15 | 125 | -448 | 26 | 493 | -387 |
Earnings Per Share EPS Growth | 3.69 | 30.75 | -110.76 | 6.88 | 97.29 | -117.20 |
EPS Growth | - | - | - | -92.93% | - | - |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
United States of America United States of America Growth | 853.06 | 1,119 | 1,231 | 1,466 |
Japan Japan Growth | 423.63 | 269.22 | 333.33 | 198.01 |
Others Others Growth | 94.97 | 153.08 | 150.59 | 67.75 |
Europe Europe Growth | 193.88 | - | - | - |
Total Total Growth | 1,566 | 1,541 | 1,715 | 2,124 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,104 | 1,148 | 1,149 | 1,384 | 1,555 | 1,325 |
Total Debt Total Debt Growth | 299 | 485 | 564 | 722 | 1,129 | 1,037 |
Net Cash (Debt) Net Cash Growth | 805 | 663 | 585 | 662 | 426 | 288 |
Net Cash Growth | 22.71% | 13.33% | -11.63% | 55.40% | 47.92% | -0.69% |
Net Cash Per Share Net Cash Per Share Growth | 197.80 | 163.11 | 144.64 | 175.05 | 84.01 | 87.22 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 68 | -73 | -79 | 277 | 16 |
Capital Expenditures CapEx Growth | - | -12 | -21 | -31 | -7 | -6 |
Free Cash Flow Free Cash Flow Growth | - | 56 | -94 | -110 | 270 | 10 |
Free Cash Flow Growth | - | - | - | - | 2600.00% | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 74.98% | 76.68% | 72.48% | 69.62% | 73.30% | 54.91% |
Operating Margin | -2.46% | 5.30% | -8.82% | 0.29% | 23.96% | -12.69% |
Pretax Margin | 1.48% | 8.37% | -28.03% | 3.44% | 24.01% | -29.61% |
Profit Margin | 1.05% | 7.99% | -29.07% | 1.52% | 23.21% | -29.23% |
FCF Margin | - | 3.58% | -6.10% | -6.41% | 12.71% | 0.76% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 92.79 | 14.33 | - | 74.68 | 4.53 | - |
Forward PE | - | 22.99 | 22.99 | 22.99 | 22.99 | 22.99 |
P/FCF Ratio | 24.86 | 31.98 | - | - | 8.28 | 173.29 |
PS Ratio | 0.98 | 1.14 | 0.97 | 1.13 | 1.05 | 1.31 |